↓ Skip to main content

Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage

Overview of attention for article published in Frontiers in oncology, July 2020
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 X users

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
Published in
Frontiers in oncology, July 2020
DOI 10.3389/fonc.2020.00902
Pubmed ID
Authors

Xiuwen Guan, Fei Ma, Xiaoying Sun, Chunxiao Li, Lixi Li, Fang Liang, Shaochuan Li, Zongbi Yi, Binliang Liu, Binghe Xu

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 15%
Researcher 5 15%
Student > Ph. D. Student 3 9%
Other 2 6%
Student > Doctoral Student 2 6%
Other 2 6%
Unknown 14 42%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 12%
Immunology and Microbiology 4 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Medicine and Dentistry 3 9%
Computer Science 1 3%
Other 3 9%
Unknown 15 45%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2020.
All research outputs
#20,320,284
of 25,838,141 outputs
Outputs from Frontiers in oncology
#9,506
of 22,812 outputs
Outputs of similar age
#316,072
of 432,191 outputs
Outputs of similar age from Frontiers in oncology
#229
of 524 outputs
Altmetric has tracked 25,838,141 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,812 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,191 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 524 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.